Table 1 Results of laboratory investigations
Investigation | Day of the illness | Follow up visit (day) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
4 | 5 | 6 | 7 | 8 | 9 | 13 | 18 | 19 | 20 | 50 | |
Hb (g/dl) | 12.8 | 14.2 | 13 | 11 | 10.1 | 8.1 | 9.8 | 9.6 | 9.3 | 9.4 | 11.6 |
Hct (%) | 40.3 | 42.8 | 40.4 | 39 | 30.6 | 30 | 35 | 36 | 38 | 39 | 41 |
WBC (× 10 3/ μL) | 5.9 | 3.69 | 3.4 | 4.3 | 11 | 12 | 8 | 10.3 | 8 | 9.5 | 7 |
Platelet (× 10 3/ μL) | 179 | 55 | 7 | 10 | 11 | 53 | 37 | 91 | 98 | 150 | 322 |
AST (U/L) | 47 | 227 | 14,275 | 5046 | 3975 | 2417 | 311 | 67 | 48 | 81 | 44 |
ALT (U/L) | 37 | 129 | 4419 | 2338 | 2390 | 1799 | 500 | 82 | 19 | 14 | 37 |
ALP (U/L) | 168 | 131 | 122 | ||||||||
GGT (U/L) | 238 | 153 | 87 | ||||||||
Total Bilirubin (mg/dl) Ref range 0.2–1.2 | 0.6 | 0.5 | 1.3 | 4.9 | 4.9 | 6.1 | 10.8 | 18.6 | 16.2 | 15.6 | 1.2 |
Direct Bilirubin (mg/dl) Ref range 0–0.5 | 0.3 | 0.3 | 0.8 | 2.1 | 3.2 | 5 | 8.3 | 14.2 | 12 | 10 | 0.59 |
PT/INR | 1.99 | 2.8 | 2.89 | 1.41 | 1.16 | 1.02 | 1.1 | ||||
pH | 7.3 | 7.27 | 7.23 | 7.3 | 7.3 | 7.4 | 7.4 | 7.41 | 7.39 | ||
Lactate (mmol/l) | 2.7 | 7.3 | 8.2 | 3.5 | 2.6 | 2 | 1.5 | 1.1 | 0.9 | ||
Creatinine (mg/dl) | 1.1 | 1.2 | 3.4 | 4.8 | 1.8 | 2.3 | 2.1 | 4.1 | 2.8 | 1.53 | |
Events | Critical phase started | ICU admission & CRRT | CRRT + Cytosorb | CRRT + Cytosorb | TPE 1st cycle | TPE 2nd cycle | Extubate | ||||